Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches

Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor prognosis and rising incidence. Late detection and a particularly aggressive biology are the major challenges which determine therapeutic failure. In this review, we present the current status and the recent advances i...

Descripción completa

Detalles Bibliográficos
Autores principales: Orth, Michael, Metzger, Philipp, Gerum, Sabine, Mayerle, Julia, Schneider, Günter, Belka, Claus, Schnurr, Maximilian, Lauber, Kirsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688256/
https://www.ncbi.nlm.nih.gov/pubmed/31395068
http://dx.doi.org/10.1186/s13014-019-1345-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688256/
https://www.ncbi.nlm.nih.gov/pubmed/31395068
http://dx.doi.org/10.1186/s13014-019-1345-6

Ejemplares similares